查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878873

口服藥物遞送市場－全球產業規模、佔有率、趨勢、機會和預測，按劑型、類型、治療領域、最終用戶、地區和競爭格局分類，2020-2030年預測

Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Formulation, By Type, By Therapy Area, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球口服藥物遞送市場規模為1,297.7億美元，預計到2030年將以7.80%的複合年成長率成長至2,036.5億美元。全球口服藥物遞送市場涵蓋了製藥業中致力於開發、生產和銷售口服給藥治療藥物的細分領域。與其他給藥方式相比，口服給藥因其固有的便利性、易於給藥以及更高的患者依從性而備受青睞。推動該市場成長的關鍵因素包括心血管疾病、糖尿病和癌症等慢性疾病在全球範圍內的日益普遍，這些疾病需要長期服藥治療。

市場概覽
預測期 2026-2030
2024年市場規模 1297.7億美元
2030年市場規模 2036.5億美元
2025-2030年複合年成長率 7.8%
成長最快的細分市場 片劑
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球口服藥物遞送市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依劑型（錠劑、膠囊、滴劑、液體或糖漿）分類
    • 按類型（控釋片、口腔崩解片、其他）
    • 依治療領域（腫瘤科、肌肉骨骼科、免疫科、胃腸科、呼吸科、心血管科、其他）
    • 按最終使用者（醫院、門診手術中心、診斷中心、診所、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美口服藥物遞送市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲口服藥物遞送市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區口服藥物遞送市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲口服藥物遞送市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲口服藥物遞送市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球口服藥物傳遞市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Novartis AG
  • Biocon Ltd.
  • NovoNordisk A/S
  • F.Hoffmann-La Roche Ltd.
  • Bayer AG
  • Emishphere Technologies Inc.
  • Enteris Biopharma Inc.
  • Merrion Pharmaceuticals Plc.
  • Amgen Inc.
  • Pfizer Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 7236

The Global Oral Drug Delivery Market, valued at USD 129.77 Billion in 2024, is projected to experience a CAGR of 7.80% to reach USD 203.65 Billion by 2030. The Global Oral Drug Delivery Market encompasses the segment of the pharmaceutical industry dedicated to developing, manufacturing, and commercializing therapeutic agents administered via the oral route. This method is highly favored due to its inherent patient convenience, ease of administration, and potential for improved compliance compared to other delivery methods. Key drivers propelling this market include the increasing global prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer, which necessitate long-term medication regimens.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 129.77 Billion
Market Size 2030USD 203.65 Billion
CAGR 2025-20307.8%
Fastest Growing SegmentTablets
Largest MarketNorth America

Key Market Drivers

Technological advancements in drug delivery systems and expanded investment in pharmaceutical research and development exert considerable influence on the Global Oral Drug Delivery Market. Innovations in solubility enhancement, controlled release mechanisms, and targeted delivery are broadening the range of orally administered therapies, including complex molecules once limited to injectable routes. These developments improve drug stability, bioavailability, and therapeutic precision. For instance, according to Fierce Biotech, in April 2025, Roche acquired Carmot Therapeutics for $2.7 billion in late 2023, securing access to three GLP-1 receptor agonists with potential for treating obesity, including oral administration. Such strategic investments emphasize the industry's dedication to patient-friendly oral formulations.

Key Market Challenges

A significant challenge impeding market expansion for oral drug delivery is the stringent regulatory approval processes. These complex procedures inherently increase the time and financial investment required to bring new oral formulations to market. This extended development timeline and heightened cost create substantial barriers for pharmaceutical companies, particularly those developing innovative therapies, by prolonging the period before potential revenue generation.

Key Market Trends

The development of personalized oral therapies is a significant trend reshaping the Global Oral Drug Delivery Market by moving towards treatments tailored to individual patient profiles. This approach leverages advancements in diagnostics and genomics to customize drug selection, dosage, and formulation, enhancing therapeutic efficacy and minimizing adverse effects. According to the Personalized Medicine Coalition (PMC), in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities. These approvals underscore a growing industry commitment to individualized treatment pathways.

Key Market Players

  • Novartis AG
  • Biocon Ltd.
  • NovoNordisk A/S
  • F.Hoffmann-La Roche Ltd.
  • Bayer AG
  • Emishphere Technologies Inc.
  • Enteris Biopharma Inc.
  • Merrion Pharmaceuticals Plc.
  • Amgen Inc.
  • Pfizer Inc.

Report Scope:

In this report, the Global Oral Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Drug Delivery Market, By Formulation:

  • Tablets
  • Capsules
  • Drops
  • Liquid or Syrup

Oral Drug Delivery Market, By Type:

  • Controlled Release
  • Orodispersible Tablets
  • Others

Oral Drug Delivery Market, By Therapy Area:

  • Oncology
  • Musculoskeletal
  • Immunology
  • Gastrointestinal
  • Respiratory
  • Cardiovascular
  • Others

Oral Drug Delivery Market, By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostic Centres
  • Clinics
  • Others

Oral Drug Delivery Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Drug Delivery Market.

Available Customizations:

Global Oral Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Drug Delivery Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
    • 5.2.2. By Type (Controlled Release, Orodispersible Tablets, Others)
    • 5.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)
    • 5.2.4. By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Oral Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Formulation
    • 6.2.2. By Type
    • 6.2.3. By Therapy Area
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Drug Delivery Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Formulation
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Therapy Area
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Oral Drug Delivery Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Formulation
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Therapy Area
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Oral Drug Delivery Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Formulation
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Therapy Area
        • 6.3.3.2.4. By End User

7. Europe Oral Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Formulation
    • 7.2.2. By Type
    • 7.2.3. By Therapy Area
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oral Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Formulation
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Therapy Area
        • 7.3.1.2.4. By End User
    • 7.3.2. France Oral Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Formulation
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Therapy Area
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Oral Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Formulation
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Therapy Area
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Oral Drug Delivery Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Formulation
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Therapy Area
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Oral Drug Delivery Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Formulation
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Therapy Area
        • 7.3.5.2.4. By End User

8. Asia Pacific Oral Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Formulation
    • 8.2.2. By Type
    • 8.2.3. By Therapy Area
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oral Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Formulation
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Therapy Area
        • 8.3.1.2.4. By End User
    • 8.3.2. India Oral Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Formulation
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Therapy Area
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Oral Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Formulation
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Therapy Area
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Oral Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Formulation
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Therapy Area
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Oral Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Formulation
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Therapy Area
        • 8.3.5.2.4. By End User

9. Middle East & Africa Oral Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Formulation
    • 9.2.2. By Type
    • 9.2.3. By Therapy Area
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oral Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Formulation
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Therapy Area
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Oral Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Formulation
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Therapy Area
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Oral Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Formulation
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Therapy Area
        • 9.3.3.2.4. By End User

10. South America Oral Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Formulation
    • 10.2.2. By Type
    • 10.2.3. By Therapy Area
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oral Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Formulation
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Therapy Area
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Oral Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Formulation
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Therapy Area
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Oral Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Formulation
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Therapy Area
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oral Drug Delivery Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Novartis AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biocon Ltd.
  • 15.3. NovoNordisk A/S
  • 15.4. F.Hoffmann-La Roche Ltd.
  • 15.5. Bayer AG
  • 15.6. Emishphere Technologies Inc.
  • 15.7. Enteris Biopharma Inc.
  • 15.8. Merrion Pharmaceuticals Plc.
  • 15.9. Amgen Inc.
  • 15.10. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer